Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

312 Views

H2. HIV: Prevention

Poster Session: HIV: Prevention

(P-512) Changes in Renal Function After Switching from Emtricitabine/Tenofovir Disoproxil Fumarate to Emtricitabine/Tenofovir Alafenamide Fumarate for HIV Pre‑exposure Prophylaxis (PrEP): A Real-World Study

Thursday, October 17, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Co-Author(s)

KI

Kaori L. Ito, PhD, OTR/L

Gilead Sciences, Inc.
Foster City, California, United States

Co-Author(s)

XH

Xiwen Huang, PhD

Gilead Sciences, Inc.
Foster City, California, United States
SP

Seojin Park, PharmD, MS

Gilead Sciences, Inc.
Foster City, California, United States
Li Tao, MD, PhD

Director
Gilead Sciences
Foster City, CA, United States

Presenting Author(s)

JG

Joshua Gruber, PhD MPH (he/him/his)

Director, HIV Global Medical Affairs
Gilead Sciences
Forest City, California, United States